The future of telemedicine after COVID-19
The use of telemedicine, or remote clinical consultations, was limited in most OECD countries before the COVID‑19 pandemic, held back by regulatory barriers and hesitancy from patients and providers. In early 2020, as COVID‑19 massively disrupted in-person care, governments moved quickly to promote the use of telemedicine. The number of teleconsultations skyrocketed, playing a vital role in maintaining access to care, but only partly offsetting reductions in in-person care.